Themis Medicare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/08/2025 ,inter alia, to consider and approve unaudited financial results ....
THEMISMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Themis Medicare has informed BSE/NSE that its Board of Directors will meet on 1st August 2025 to consider and approve the unaudited standalone and consolidated financial results for the quarter ended 30th June 2025, along with the auditor's limited review report. The company also confirmed that the trading window for designated persons remained closed from 1st July 2025 until 48 hours after publication of the results, as required under insider trading rules. This is a routine SEBI Regulation 29 compliance filing ahead of the quarterly results announcement. No actual financial numbers have been disclosed in this notice.
No direct impact on stock price from this intimation; investors should watch for the actual Q1 results on/after 1st August 2025 for any meaningful performance signals. The closed trading window is standard procedure.